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Improving access to antiretrovirals in rural South Africa – 
a call to action
South Africa (SA) already has the world’s biggest 
antiretroviral (ARV) programme. With the 
introduction of extended criteria for initiating ARVs, 
the National Department of Health (NDoH) wishes 
to increase the number of people on ARVs by around 
two million over the next 2 years. Adoption of a chronic disease 
management model, with extended task shifting, decentralisation 
and new approaches to distribution of ARVs, must be embraced 
if this is to be successfully achieved without huge increases in 
resources. In this editorial we discuss the need for change, and the 
current substantial blocks to progress (principally in prescribing and 
dispensing legislation) that contradict national treatment guidance 
and should be addressed as a matter of urgency. In addition, we draw 
attention to threatened regulatory changes that may further worsen 
the situation.
HIV management as a chronic 
condition
The implementation of nurse prescribing of ARVs, through nurse-
initiated management of antiretroviral treatment, has been a great 
success and has proved not to be inferior to doctor-monitored 
ART.[1,2] However, this very success is feeding the challenges. Patients 
in ever-growing numbers are required to attend nurse-managed 
clinics monthly, or at best 3-monthly, to obtain their medication – 
whether or not they also need to attend for care. Consequently 
large workloads have caused a ‘vicious tangle’ of problems in 
clinics, including high staff stress, turnover, sickness and shortages, 
and therefore poor-quality care (including reduced attention to 
adherence and identification of treatment failure[3]). These affect the 
patient experience through long waiting times and lack of person-
centred care, and are likely to contribute to the substantial losses 
to follow-up and undermine effective disease control.[4,5] Increasing 
patient numbers will put an additional burden on the infrastructure 
of health facilities, for example waiting areas and storage space for 
increasing stocks of ARVs.
Regular visits, which may be as frequent as monthly, with face-
to-face counselling by a pharmacist, are no longer the gold standard 
in resource-rich settings, where demedicalisation of patients and 
efficient use of resources are also drivers for change. In such a 
setting, 6- or 12-monthly review by a clinician is the norm for stable 
patients, with resources concentrated on patients with higher clinical 
needs. This shift has been recognised in SA in part, with 3-monthly 
supplies being issued where stocks allow, but further flexibility is now 
essential.
There is a cry for changes, including in our national guidelines,[6] 
that will see the adoption of a chronic disease management model 
with demedicalisation of healthy patients and supported self-care. [7-10] 
Consequent improved efficiencies in respect of nurse time can enable 
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an increased clinical focus of attention on those whose need is 
highest.[11] Such models depend on stable patients being able to obtain 
a safe and regular supply of medication between clinical reviews. This 
in turn depends on: (i) having a trained clinician able to determine 
which patients are clinically stable, and ‘enable’ their future medication 
to be issued, at appropriate intervals, until the next clinical review; (ii) 
a pharmacist, pharmacist’s assistant or other trained support person 
able to provide ‘between-review’ medication for individual patients 
at appropriate intervals; (iii) ‘between-review’ medication being 
available at appropriate (convenient and safe) locations; and (iv) 
clinical review intervals being determined according to clinical need 
and national guidelines, and not hampered by over-restrictive laws, 
interpretations of those laws or tertiary legislation (such as Good 
Practice standards).
All of this, of course, requires intelligent implementation, with the 
presence of some simple, essential checks and balances such as are 
standard for chronic disease management, e.g. the ability to identify, 
and act on, non-attendance.
Barriers to progress in rural clinics
In rural SA, there are barriers to achieving these steps. About 40% of 
the SA population is rural, and this includes areas with the highest 
prevalence of HIV in the world. There are concerns about the ability 
of nurses to prescribe safely when clinics are ‘overloaded with the 
healthy’[10] and nurses are dispensing medication individually to each 
patient. The potential for errors would be much reduced if this task 
were to be systematised, and nurses freed to prioritise their time and 
attention on the clinically needy, only seeing stable patients at routine 
review.
Rural nurses work in the absence of ‘individual patient level’ 
pharmacy and medical support, and are operating in terms of 
an exceptional permit (section 56(6) of the Nursing Act).[12] 
Under this Act, they are required to do all of their dispensing, 
and cannot use other clinic personnel (as listed in (ii) above) to 
dispense ‘between-review’ repeat medication. Hospital pharmacies 
are generally remote from their clinics, and providing detailed 
support for ‘between-review’ prescribing will necessitate substantial 
additional resources. Rural areas also lack access to private sector 
community pharmacies, which might otherwise be able to support 
such programmes.
If nurses are enabled to ‘trigger’ ‘between-review’ prescriptions 
of medication for patients in a rural setting, the use of centralised 
pharmacy support using postal or courier delivery will be 
hampered by the lack of formal postal or residential addresses in 
rural areas.
There has been a national shift, supported by an NDoH circular 
(July 2010, unpublished), for at least first-line ARV regimens 
to be available as 3-monthly supplies (as opposed to monthly), 
which, locked as it is to attendance, leads to some improvement. 
However, medicine stock-outs (threatened or actual) currently 
pitch nurses and patients backwards from 3-monthly into monthly 
clinic attendance, with all its negative impacts on quality of care 
and patient quality of life. In addition, there are concerning reports 
from some rural clinics that the shift to 3-monthly supplies has 
met with a negative reaction from clinic managers who are angry 
because there has been a consequent drop in the clinic attendance 
head count.
Legislation and guidance on the interval for clinical review are 
currently contradictory. Conservatively defined, adult, established-
stable ARV patients only require annual clinical review, with blood 
tests, according to national guidelines[6] – as long as simple problem-
screening questions are used when interim medication is collected. 
However, currently section 22A(6)(f) of the Medicines and Related 
Substances Act[13] indicates that medication should not be repeated 
beyond 6 months from the original date of the prescription: in other 
words, a prescriber must sign a new prescription, and the implication 
is that the patient should be reviewed. There are reports that this 
requirement is widely circumvented in the private sector for some 
conditions (such as stable HIV and controlled hypertension) where 
the evidence, and clinical guidance, supports only annual clinical 
review.
An additional problem is posed by the status of nurses as 
authorised prescribers. There is an impasse between the national 
(and provincial) departments of health, which wish to see nurses 
recognised as authorised prescribers able to issue prescriptions 
that can then be dispensed by pharmacists or pharmacist’s 
assistants, and the South African Pharmacy Council, which holds 
that they are not authorised prescribers.[14] The Pharmacy Council 
seems determined to set ever-higher standards for each element 
of the dispensing and medication supply process. In this regard 
they risk allowing the perfect to be the enemy of the good. Things 
may get worse. Draft amendments to the Rules relating to Good 
Pharmacy Practice would restrict the ability of pharmacies (both 
community and institutional) to operate mobile services and to 
deliver medicines once dispensed.[15] These draft rules, as well as 
rules that have been issued in final form,[16] have also introduced 
restrictions on the use of technological options such as remote 
automated dispensing units. These options may not be easily 
applicable in the public sector, yet should not be discounted as 
potential future solutions.
This impasse contributes to the impression that the needs of 
hundreds of thousands of patients a day in rural public sector health 
clinics, and their nurses, are invisible to some policymakers.
Finding solutions
Chronic disease management systems will require careful piloting 
and evaluation, with support of the nurses, as well as system 
changes and safety nets. However, such approaches contain natural 
incentives for nurses (through the prospect of rationalised and 
rewarding workloads) and patients (through demedicalisation and 
reduced attendance) to achieve stable status by paying increased 
attention to adherence and to viral load results. It is therefore 
essential to overcome the barriers in their way. A prerequisite for 
implementation of chronic care models for effective decongestion of 
primary healthcare facilities is a stable, flexible and patient-centred 
supply of ARVs, with refills for at least 3 months and delivered close 
to patients’ homes, supported by national legislation. Underpinning 
this is dependence on the willingness and flexibility of provincial and 
hospital pharmacy managers to provide for sufficient buffer stocks 
of ARVs.
A variety of chronic disease management models are being 
explored or used, both in SA and elsewhere, some endorsed by the 
WHO and included in national guidelines.[17] Adherence clubs can 
shift healthy patients out of the clinics, and enable them to collect 
‘between-review’ medication that has been prepacked and labelled 
by pharmacy staff. Some hospital pharmacies are supporting 
community pick-up points (such as churches), supported by 
pharmacists’ assistants. A chronic dispensing model has been 
implemented in National Health Insurance urban and semi-
urban pilot areas and the Western Cape public sector, successfully 
delegating ordering, warehousing, prepacking and labelling of 
chronic medication to a public-private entity that delivers the 
medicine packs to the facility for fast-tracked collection by patients. 
A central chronic medicine dispensing and distribution programme, 
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providing distribution to designated pick-up points, has also been 
started in the public sector.
However, for their implementation in rural Department of Health 
clinics, every one of these solutions depends either on new legal 
flexibilities for nurse prescribing or the reintroduction of doctors 
and pharmacists into routine rural HIV care. Clearly the latter is 
not a viable option. The only existing alternative for those desperate 
for change is circumvention, reports of which are becoming more 
widespread.
Call to action
Those keen to implement efficiency and quality in primary care 
will not be able to pilot and implement solutions to the above 
conundrums until SA rural nurses are unlocked from huge-scale 
dispensing of medication and freed to focus more closely on clinical 
need, whether for HIV or other chronic diseases.
• The Medicines Control Council (as custodians of the Medicines
Act) and the SA Nursing Council (whose legislation permits public 
sector nurses to ‘supply’ medicines) should give a clear and positive 
direction.
• The South African Pharmacy Council is urged to support and
enable the following essential measures:
• Pragmatically interpret existing legislation so as to provide
for the recognition of nurses as authorised prescribers (albeit
through an exceptional mechanism, until specialist registers are
created and populated).
• Allow and encourage patient-centred and decentralised drug
supplies with a minimum of 3 months’ refill for stable patients.
• Allow for mobile and decentralised treatment points to be
managed with regular support, but without direct personal
supervision by pharmacists.
• The NDoH is urged to put in place logistical and legislative
measures to:
• Ensure continuous availability of safe and appropriate ARVs for
all eligible patients.
• Optimise access to these appropriate medicines closer to patients’ 
homes, through community and mobile dispensing and allowing 
multiple months’ supplies.
• Consider possible amendments to the Medicines Act to enable
clinicians to tailor clinical follow-up, within appropriate
medication issuing systems and according to individual clinical
need, up to 12 months.
• Ensure responsibility and accountability for a range of systems of 
medication issuing that can be clearly, if flexibly, defined.
Andy Gray
Senior Lecturer, Division of Pharmacology, Discipline of 
Pharmaceutical Sciences, School of Clinical Medicine, College of 
Health Sciences, Nelson R Mandela School of Medicine, University of 
KwaZulu-Natal, Durban, South Africa
Francesca Conradie
President, Southern African HIV Clinicians Society
Talitha Crowley
Lecturer, Division of Nursing, Faculty of Medicine and Health Sciences, 
Stellenbosch University, Tygerberg, Cape Town, South Africa
Bernhard Gaede
Head of Department, Discipline of Family Medicine, School of Clinical 
Medicine, College of Health Sciences, Nelson R Mandela School of 
Medicine, University of KwaZulu-Natal, Durban, South Africa
Tinne Gils, Amir Shroufi
Regional Pharmacy Manager and Deputy Medical Coordinator, 
Médecins Sans Frontières South Africa
Bella Hwang
Programme Manager, Stop Stock Outs Project, South Africa
Desmond Kegakilwe
Chair, RuDASA, South Africa
Jenny Nash
Amathole District Clinical Specialist Team, Eastern Cape, South Africa
Prinitha Pillay
Human Resources for Health and Policy Implementation Programme 
Manager, Rural Health Advocacy Project, South Africa
Stacie C Stende
Senior Technical Advisor, HIV/TB/ID (based in Cape Town, 
South Africa), Jhpiego
Francois Venter
Deputy Executive Director, Wits Reproductive Health and HIV 
Institute, University of the Witwatersrand, Johannesburg, South Africa
Philippa Matthews
Primary Care Development Facilitator, Africa Centre for Health 
and Population Studies, University of KwaZulu-Natal, Durban, 
South Africa
Corresponding author: P Matthews (pmatthews@africacentre.ac.za)
1. Nyasulu JC, Muchiri E, Mazwi SL, Ratshefola M. NIMART rollout to primary healthcare facilities
increases access to ARVs in Johannesburg. S Afr Med J 2013;103(4):232-236. [http://dx.doi.
org/10.7196/SAMJ.6380]
2. Sanne I, Orrell C, Fox MP et al. Nurse versus doctor management of HIV-infected patients receiving 
antiretroviral therapy (CIPRA-SA): Randomised non-inferiority trial. Lancet 2010;376:33-40. [http://
dx.doi.org/10.1016/SO140-6736(10)60894-X]
3. Mutevedzi P, Lessells RJ, Heller T, Barnighausen T, Cooke G, Newell M-L. Scale-up of decentralized 
HIV treatment programme in rural KwaZulu-Natal, South Africa: Does rapid expansion affect
patient outcomes? Bull World Health Organ 2010;88(8):593-600 [http://dx.doi.org/10.2471/
BLT.09.069419]
4. Rosen S, Fox MP, Gill CJ. Patient retention in antiretroviral therapy programs in sub-Saharan Africa: A 
systematic review. PLoS Med 2007;4:e298 [http://dx.doi.org/10.1371/journal.pmed.0040298]
5. Lessells RJ, Mutevedzi P, Cooke GS, Newell M-L. Retention in HIV care for individuals not yet
eligible for antiretroviral therapy: Rural KwaZulu-Natal, South Africa. J Acquir Immune Defic Syndr. 
2011;56:e79-86. [http://dx.doi.org/10.1097/QAI.1090b1013e3182075ae3182072]
6. Department of Health, South Africa. National consolidated guidelines for the prevention of mother-
to-child transmission of HIV (PMTCT) and the management of HIV in children, adolescents and 
adults. Section 2.1-2.5, p. 20/ section 6.6.6, p. 70. 2014. http://www.hst.org.za/sites/default/files/HIV_
Guidelines_Jan%202015_YP_0.pdf (accessed 24 June 2015).
7. Mutevedzi P, Lessells RJ, Newell M-L. Disengagement from care in a decentralized primary health 
care antiretroviral treatment programme: Cohort study in rural South Africa. Trop Med Int Health 
2013;18(8):934-941. [http://dx.doi.org/10.1111/tmi.12135]
8. Deeks S, Lewin SR, Havlir DV. The end of AIDS: HIV infection as a chronic disease. Lancet
2013;382(9903):1525-1233. [http://dx.doi.org/10.1016/S0140-6736(13)61809-7]
9. Beaglehole R, Epping-Jordan J, Patel V, et al. Improving the prevention and management of chronic 
disease in low-income and middle-income countries: A priority for primary health care. Lancet
2008;372(9642):940-949. [http://dx.doi.org/10.1016/S0140-6736(08)61404-X]
10. Ellman T. Demedicalizing AIDS Prevention and Treatment in Africa. N Engl J Med 2015;372(4):303-
305. [http://dx.doi.org/10.1056/NEJMp1414730]
11. Murray CJL. Maximizing antiretroviral therapy in developing countries: The dual challenge of
efficiency and quality. JAMA 2015;313(4):359-360. [http://dx.doi.org/10.1001/jama.2014.16376] 
12. Republic of South Africa. Nursing Act (Act 33 of 2005). http://www.sanc.co.za/pdf/Nursing%20
Act%202005.pdf (accessed 24 June 2015).
13. Republic of South Africa. Medicines and Related Substances Act (Act 101 of 1965), as amended. http://
mccza.com/genericDocuments/Act_101_of_1965_published_2003.pdf (accessed 24 June 2015).
14. Gray A. Prescribing and dispensing by nurses – neglected steps in the legislative process. HIV Nursing 
2010;1(2):28-31. 
15. South African Pharmacy Council. Rules Relating to Good Pharmacy Practice. Board Notice No. 49 of 
2015. Government Gazette No. 38511 (27 February 2015).
16. South African Pharmacy Council. Rules Relating to Good Pharmacy Practice. Board Notice No. 50 of 
2015. Government Gazette No. 38511 (27 February 2015).
17. Bemelmans M, Baert S, Goemaere E, et al. Community-supported models of care for people on HIV 
treatment in sub-Saharan Africa. Trop Med Int Health 2014;19(8):968-977 [http://dx.doi.org/10.1111/
tmi.12332]
S Afr Med J 2015;105(8):638-640. DOI:10.7196/SAMJnew.8265
640       August 2015, Vol. 105, No. 8
